Ketamine + Cognitive Training for Suicidality in the Medical Setting: Pilot
Status:
Active, not recruiting
Trial end date:
2023-03-01
Target enrollment:
Participant gender:
Summary
This project seeks to identify the acute and longer-term impact of a single dose of
intravenous ketamine among suicidal patients referred for psychiatric consultation/liaison in
the medical inpatient setting. The investigators will then test whether ketamine's rapid
effects can be extended by introducing helpful information delivered by a computer-based
training protocol. This work could ultimately lead to the ability to treat suicidality more
efficiently and with broader dissemination by rapidly priming the brain for helpful forms of
learning.